Alleviation of minimal brain dysfunction with 2-[(3,4-dichloroph

Details Alleviation of minimal brain dysfunction with 2-[(3,4-dichloroph Alleviation of minimal brain dysfunction with 2-[(3,4-dichloroph

1977-11-16

1979-02-27

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Parasitic organism or component thereof or substance...

A61K 31415

Patent

active

041419855

ABSTRACT:
A method useful for alleviating minimal brain dysfunction in humans comprises internally administering to a human an effective amount of 2-[(3,4-dichlorophenoxy)methyl]-2-imidazoline or a pharmaceutically-acceptable salt thereof.

REFERENCES:
patent: 3449355 (1969-06-01), White
patent: 3860719 (1975-01-01), Marshall
Sprague et al., Pediatric Clinics of N. America, vol. 20, No. 3, 719-735 (1973).
Krager et al., N.E.J. Med. 201(21); 1118-1120, Nov. 21, 1974.
Weiss et al., CMA Journal, vol. 104, pp. 20-25 (1971).
Physicians Desk Reference 29th Ed. (1975), pp. 709-710.
Chien & Kaplan, Curr. Therap. Res., 11(7), 471-474 (1969).
Chien & Kaplan, Curr. Therap. Res., 13(6), 350-352 (1971).
Fink & Irwin, Curr. Therap. Res., 18(4), 590-596 (1975).

Affiliated with

Also associated with

Rating

Alleviation of minimal brain dysfunction with 2-[(3,4-dichloroph does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alleviation of minimal brain dysfunction with 2-[(3,4-dichloroph, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alleviation of minimal brain dysfunction with 2-[(3,4-dichloroph will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-723040